Satellos Bioscience Inc.: Satellos Bioscience Announces 2023 Q1 Financial Results and Operational Highlights
- $55 million equity financing closed- Resourced to advance lead drug candidate into clinical trialsToronto, Ontario--(Newsfile Corp. - May 30, 2023) - Satellos Bioscience Inc. (TSXV: MSCL) ("Satellos"